{"url_path":"/sec/mmed/10-k/2026/item-9b","section_key":"item-9b","section_title":"Item 9B Other Information","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-06-29","source_url":"https://www.sec.gov/Archives/edgar/data/2062583/0001628280-26-045915-index.html","accession_number":"0001628280-26-045915","cik":"0002062583","ticker":"MMED","issuer_name":"MiniMed Group, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2062583/0001628280-26-045915-index.html","primary_entity_key":"0002062583","primary_entity_name":"MiniMed Group, Inc."},"word_count":50,"has_tables":true,"body_markdown":"Item 9B. Other Information\n\nRule 10b5-1 Director and Officer Trading Arrangements\n\nDuring the quarter ended April 24, 2026, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K."}